Cargando…
HGFL-mediated RON signaling supports breast cancer stem cell phenotypes via activation of non-canonical β-catenin signaling
Breast cancer stem cells (BCSCs), which drive tumor progression, recurrence, and metastasis, are considered a major challenge for breast cancer treatments, thus the discovery of novel pathways regulating BCSC maintenance remains essential to develop new strategies to effectively target this populati...
Autores principales: | Ruiz-Torres, Sasha J., Benight, Nancy M., Karns, Rebekah A., Lower, Elyse E., Guan, Jun-Lin, Waltz, Susan E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601703/ https://www.ncbi.nlm.nih.gov/pubmed/28938607 http://dx.doi.org/10.18632/oncotarget.19441 |
Ejemplares similares
-
RON (MST1R) and HGFL (MST1) Co-Overexpression Supports Breast Tumorigenesis through Autocrine and Paracrine Cellular Crosstalk
por: Hunt, Brian G., et al.
Publicado: (2022) -
HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses
por: Benight, Nancy M., et al.
Publicado: (2015) -
The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor positive breast cancers
por: Privette Vinnedge, Lisa M., et al.
Publicado: (2014) -
Vitamin D(3)-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity
por: Johnson, Abby L., et al.
Publicado: (2015) -
Prostate tumor RON receptor signaling mediates macrophage recruitment to drive androgen deprivation therapy resistance through Gas6‐mediated Axl and RON signaling
por: Brown, Nicholas E., et al.
Publicado: (2022)